US20050090765A1 - Dual Action Aspiration Biopsy Needle - Google Patents

Dual Action Aspiration Biopsy Needle Download PDF

Info

Publication number
US20050090765A1
US20050090765A1 US10/905,599 US90559905A US2005090765A1 US 20050090765 A1 US20050090765 A1 US 20050090765A1 US 90559905 A US90559905 A US 90559905A US 2005090765 A1 US2005090765 A1 US 2005090765A1
Authority
US
United States
Prior art keywords
needle
slot
sharp edge
proximal
cellular material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/905,599
Inventor
John Fisher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical Device Technologies Inc
Original Assignee
Biopsy Sciences LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/682,252 external-priority patent/US20030032895A1/en
Application filed by Biopsy Sciences LLC filed Critical Biopsy Sciences LLC
Priority to US10/905,599 priority Critical patent/US20050090765A1/en
Assigned to BIOPSY SCIENCES, LLC reassignment BIOPSY SCIENCES, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: FISHER, JOHN S
Publication of US20050090765A1 publication Critical patent/US20050090765A1/en
Assigned to MEDICAL DEVICE TECHNOLOGIES, INC. reassignment MEDICAL DEVICE TECHNOLOGIES, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BIOPSY SCIENCES, LLC
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/0233Pointed or sharp biopsy instruments
    • A61B10/0266Pointed or sharp biopsy instruments means for severing sample
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/0233Pointed or sharp biopsy instruments
    • A61B10/0266Pointed or sharp biopsy instruments means for severing sample
    • A61B10/0275Pointed or sharp biopsy instruments means for severing sample with sample notch, e.g. on the side of inner stylet
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/0233Pointed or sharp biopsy instruments
    • A61B10/0283Pointed or sharp biopsy instruments with vacuum aspiration, e.g. caused by retractable plunger or by connected syringe
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/02Instruments for taking cell samples or for biopsy
    • A61B10/04Endoscopic instruments

Definitions

  • This invention relates, generally, to aspiration biopsy needles. More particularly, it relates to an aspiration biopsy needle having an enhanced cellular material collection capability.
  • biopsy procedures There are three main types of biopsy procedures.
  • a first type a conventional surgical incision is made and the patient's body is opened so that a surgeon may retrieve one or more large pieces of the tumor or lesion to be tested for malignancy.
  • This type of biopsy is very invasive, expensive to perform, and requires a considerable recovery time.
  • Inventive endeavors in the field have resulted in two improved procedures that substantially reduce the invasiveness of the biopsy procedure, as well as the expense of the procedure and the length of the recovery time.
  • the first improved procedure involves the cutting or shearing of one or more visible pieces of the tumor or lesion by a relatively large bore needle.
  • This type of biopsy is known as a core tissue biopsy and is performed with a core tissue biopsy needle.
  • the pieces of tissue are usually about one to three millimeters in length and are thus visible to the unaided eye. They cannot be immediately examined under a microscope because they are too thick for light to pass therethrough. Accordingly, they must first be sliced into a plurality of very thin slices by a tissue-slicing machine. After slicing, they are then stained with a tissue fixative e.g., formalin, glutaraldehyde, etc., and placed upon a microscope slide for diagnostic purposes.
  • a tissue fixative e.g., formalin, glutaraldehyde, etc.
  • the fixed tissue is sliced into thin sections approximately eight (8) microns thick, the tissue sections are mounted on slides and cell-selective histological stains are applied to stain the tissue prior to microscopic examination.
  • This non-frozen tissue preparation technique typically requires twenty four to forty eight (24-48) hours to complete so the pathologist's diagnosis of the breast lesion may not be available until twenty four to seventy two (24-72) hours after the biopsy specimen was removed from the breast. Accordingly, histopathological examination and diagnosis of breast lesions may be much more time-consuming than the histopathological examination and diagnosis of other types of lesions.
  • core tissue biopsy needle thus represents a significant improvement over the more invasive surgical removal of tumor or lesion specimens.
  • the need to slice the specimens causes a delay in providing the diagnosis, due to processing.
  • the diameter of core biopsy needles are typically larger than the diameter of fine needle aspiration (FNA) needles, thereby increasing the risk of procedure-related complications including bleeding, pneumothorax, and bile leakage.
  • FNA fine needle aspiration
  • core biopsy needles necessitates the purchase and maintenance of tissue slicing machines. The material must be removed from the needle, deposited onto the machine, machine-sliced, removed from the machine after slicing, stained, and deposited onto a microscope slide.
  • FIG. 1 One example of a core tissue biopsy needle is disclosed in U.S. Pat. No. 5,320,110 to Wang.
  • the Wang structure has utility in performing a pleural tissue biopsy by cutting tissue samples of the parietal pleura.
  • Wang teaches a two needle (tube-in-tube) system having a sharp edge to fix tissue while a second needle is advanced to shear off a piece of the tissue.
  • the device does not rely solely on a vacuum to draw in material as in an FNA biopsy needle and tissue is sheared off in sizeable, visible pieces, i.e., not at the cellular level.
  • a hook engages the pleural tissue and an outer cannula is advanced to cut off the hooked piece of pleural tissue.
  • This two needle system is designed to reduce the chances of a pneumothorax and thus represents a significant improvement over earlier biopsy techniques.
  • the diameter of the Wang needle as described is about 4.5 mm, which is considerably larger than an FNA biopsy needle of the novel type disclosed herein which is typically no larger than 20-22 gauge.
  • the Wang needle is not designed as a fine needle aspiration device but is designed to cut off pieces of lung pleura.
  • a large diameter needle like the Wang device measuring about 4.5 mm in diameter is inappropriate for fine needle biopsy procedures due to the high risk of complications from a large tissue puncture including bleeding, pneumothorax and bile leakage.
  • the Wang structure includes a notch formed in a first side of the large bore needle and a hole in an opposite side thereof.
  • the tissue to be cut extends into the notch and is sliced off when the outer needle or cannula is advanced as aforesaid.
  • No such opposing hole can be provided in an FNA biopsy needle because such hole would allow the escape of cellular material when it is deposited directly from the syringe barrel onto a microscope slide in which the distal tip bevel and side notch must point in the same direction.
  • the distal tip of the Wang outer needle is not hollow and therefore no tissue cutting occurs at said distal tip. All tissue cutting occurs at the side of the Wang needle where the notch is positioned.
  • the Wang needle collects relatively large samples in a knifing action, and performs no scraping action capable of collecting samples at the cellular level.
  • Wang nor any other known two needle systems include both an open distal end and a port for cutting tissue nor is any core biopsy system capable of collecting samples of cellular thickness. It should also be observed that the Wang needle is attached to a syringe barrel and includes a pressure flap.
  • biopsy tools that collect large specimens include spring-loaded core biopsy guns.
  • An example of a vacuum-assisted biopsy device is the Mammotome Biopsys® breast biopsy device.
  • the third technique is called fine needle aspiration (FNA) biopsy and is performed with an FNA biopsy needle.
  • An FNA biopsy needle scrapes cells from the tumor or lesion that are so small as to be invisible to the unaided eye.
  • the cellular material is already very thin when it is collected so there is no need to slice it to a thinner size prior to viewing it on a microscope slide because light can already pass through the thin cell layer.
  • the cellular material is deposited onto a microscope slide directly from the FNA biopsy needle, stained, and viewed so that there is less time to the final biopsy report because the slicing machine and all of the handling steps necessitated thereby are eliminated. Trauma to the patient is greatly reduced because of smaller needle diameter and because cells are scraped instead of tissue being cut in thick pieces. Complication risk is also minimized or eliminated due to smaller nozzle diameters.
  • FNA biopsy needles collect samples by aspiration; a vacuum applied to the proximal end of a hollow needle pulls severed cellular material from the lesion into the lumen of the needle. The needle is then retracted from the soft tissue so that the cellular material in the lumen can be removed for analysis. If more samples of the lesion are needed, the biopsy needle is reintroduced into the lesion.
  • FNA biopsy needle The primary distinction between an FNA biopsy needle and a core tissue biopsy needle is that the latter cuts or slices relatively large pieces of tissue from a lesion or tumor whereas the former scrapes cellular material from a lesion or tumor.
  • a core needle aspiration biopsy needle is like a knife that cuts slices of cheese and an FNA biopsy needle is like a cheese grater that scrapes small flakes of cheese.
  • the FNA biopsy procedure fails to collect a sample of sufficient size to enable definitive pathological analysis.
  • the physician must repeat the procedure, causing additional trauma to the body part undergoing biopsy and creating an additional risk of an adverse event.
  • FNA biopsy needles represent a significant improvement over more invasive procedures for performing biopsies on suspect lesions or tumors
  • FNA biopsy needles represent a significant improvement over more invasive procedures for performing biopsies on suspect lesions or tumors
  • the novel aspiration biopsy needle includes a single needle of elongate, hollow construction having a proximal end and a beveled distal end.
  • the beveled distal end of the needle is open and therefore forms a first sharp edge adapted to scrape cellular material when the needle is inserted into tissue.
  • the needle is displaced from a proximal position to a distal position during insertion.
  • the needle has a uniform diameter along a substantial part of its extent.
  • a slot is formed in the needle near the beveled distal end; the slot is transversely disposed relative to a longitudinal axis of the needle.
  • the slot is also angled relative to a transverse axis of the needle such that a bottom of the slot is positioned distal to an opening of the slot.
  • the opening of the slot includes a second sharp edge adapted to scrape tissue of cellular size when the needle is displaced from a distal position to a proximal position.
  • the novel structure further includes conventional means for applying a vacuum to a proximal end of the needle so that cellular material removed by the first sharp edge during proximal-to-distal travel of the needle is pulled into a lumen of the needle and so that cellular material removed by the second sharp edge during distal-to-proximal travel of the needle is also pulled into the lumen.
  • the novel structure also has utility when no vacuum means is employed, i.e., even if it is not affixed to a syringe barrel.
  • the cellular material is deposited from the lumen of the single FNA needle onto a slide for microscopic inspection in the absence of any need to slice said cellular material and to place said cellular material, following staining, into a formative to preserve the tissue.
  • the slot has a circumferential extent of about one half the circumference of the needle.
  • the second sharp edge is coincident with the exterior surface of the needle.
  • the second sharp edge is raised with respect to the exterior surface of said needle, and in a third embodiment, the sharp edge is recessed with respect to said exterior surface.
  • the slot is also angled relative to a transverse axis of the needle such that a bottom of the slot is positioned proximal to an opening of the slot and the second sharp edge thereby created is coincident with the exterior surface of the needle.
  • the second sharp edge of the fourth embodiment is elevated and recessed, respectively, relative to the exterior surface of the needle.
  • a first slot is formed in the needle as in the first embodiment and a second slot is formed in the needle as in the fourth embodiment.
  • the first and second slots are longitudinally spaced apart from one another.
  • a transversely disposed channel is formed in the needle and provides a second and a third sharp edge that are coincident with the exterior surface of the needle.
  • the second and third sharp edges, respectively, are elevated with respect to the exterior surface of the needle and in eleventh and twelfth embodiments, the second and third sharp edges, respectively, are recessed with respect to said exterior surface.
  • the second sharp edge is mounted for pivotal movement about a transversely disposed hinge.
  • the hinge enables the second sharp edge to open wider relative to its non-hinged position so that it may scrape off larger numbers of cellular material as the needle is displaced in a distal-to-proximal direction.
  • the third sharp edge is mounted for pivotal movement about a transversely disposed hinge and in additional embodiments, both the second and third sharp edges are so mounted.
  • a primary object of the invention is to provide a fine needle aspiration biopsy needle that collects a greater quantity of cellular material per needle insertion than conventional fine needle aspiration biopsy needles.
  • a closely related object is to accomplish the foregoing object by making a structural change to an existing FNA biopsy needle so that physicians will have a sense of familiarity when employing the improved needle.
  • a more specific object is to provide an FNA biopsy needle capable of collecting cellular material as the needle is reciprocated along its longitudinal axis at a tissue collection site.
  • FIG. 1 is a perspective view of a first embodiment of the novel aspiration biopsy needle
  • FIG. 2 is an enlarged perspective view of the distal end of the needle of said first embodiment
  • FIG. 3 is an enlarged longitudinal sectional view of the parts depicted in FIG. 2 ;
  • FIG. 4 is an enlarged perspective view of the distal end of a second embodiment
  • FIG. 5 is an enlarged longitudinal sectional view of the parts depicted in FIG. 4 ;
  • FIG. 6 is an enlarged longitudinal sectional view of a third embodiment
  • FIG. 7 is an enlarged longitudinal sectional view of a fourth embodiment
  • FIG. 8 is an enlarged longitudinal sectional view of a fifth embodiment
  • FIG. 9 is an enlarged longitudinal sectional view of a sixth embodiment
  • FIG. 10 is an enlarged longitudinal sectional view of a seventh embodiment
  • FIG. 11 is an enlarged longitudinal sectional view of a eighth embodiment
  • FIG. 12 is an enlarged sectional view of a ninth embodiment
  • FIG. 13 is an enlarged sectional view of a tenth embodiment
  • FIG. 14 is an enlarged sectional view of an eleventh embodiment
  • FIG. 15 is an enlarged sectional view of a twelfth embodiment
  • FIG. 16 is an enlarged sectional view of a thirteenth embodiment.
  • FIG. 17 is a diagrammatic view of a fourteenth embodiment where the novel biopsy device is used with an endoscope.
  • the reference numeral 10 denotes a first illustrative embodiment of the present invention.
  • the proximal end 12 of aspiration biopsy needle 10 is mounted in a LUER LOK® adapter 13 or equivalent structure to which a vacuum is applied from a remote source of negative pressure, not shown, when the leading or distal end 14 of said needle is inserted into a suspect lesion in soft tissue.
  • the sharp leading end 14 is beveled in a well-known way to form a first sharp edge that scrapes cellular material from the lesion as it travels therethrough in a proximal-to-distal direction.
  • a vacuum applied to adapter 13 pulls cellular material severed from the lesion into lumen 16 of the needle.
  • the well-known prior art procedure ends at this point, i.e., the needle having a sample of the lesion in its lumen is retracted from the soft tissue and the sample is delivered to a lab for analysis. Additional sample-taking requires additional insertions of the needle into the lesion.
  • a first innovation of this invention includes slot 18 formed in needle 10 , near first sharp edge 14 thereof.
  • Slot 18 is transversely disposed relative to a longitudinal axis of the needle.
  • a lower end or bottom of the slot is distal to the open upper end thereof.
  • a second sharp edge 20 is formed at the distal edge of the upper end of the slot. Accordingly, second sharp edge 20 scrapes cellular material from a lesion when the needle is retracted, i.e., when the needle is displaced along its longitudinal axis in a distal-to-proximal direction.
  • a physician may reciprocate needle 10 along its longitudinal axis, collecting cells of a suspect lesion that are scraped off by the first sharp edge 14 during the proximal-to-distal portion of each reciprocation, and collecting cellular aspirate of said lesion that are scraped by second sharp edge 20 during the distal-to-proximal portion of each reciprocation.
  • the chances of collecting a quantity of lesion that is sufficient for analysis is greatly enhanced by the provision of second sharp edge 20 .
  • slot 18 is approximately equal to half of the circumference of needle 10 , but that structural feature of slot 18 is not critical to this invention; the circumferential extent of said slot could be more or less than that described and depicted.
  • second sharp edge 20 is coincident or flush with the exterior surface of needle 10 in this first embodiment.
  • FIG. 4 provides a perspective view of a second embodiment of needle 10 where second sharp edge 20 a is elevated with respect to the exterior surface of needle 10 and FIG. 5 provides a longitudinal sectional view of said second embodiment.
  • the protrusion of second sharp edge 20 a above the exterior surface of the needle ensures that the cellular material collected when using this second embodiment should be greater than the amount of cellular material collected when using the first embodiment.
  • FIG. 6 provides a longitudinal sectional view of a third embodiment where second sharp edge 20 b is recessed with respect to said exterior surface.
  • the lesion not shown, is under compression as needle 10 penetrates it. Accordingly, an amount of tissue will enter into slot 18 and be scraped off during distal-to-proximal travel of needle 10 , even though sharp edge 20 b is recessed with respect to the exterior surface of the needle.
  • FIG. 7 depicts a fourth embodiment where a slot 18 a is formed transversely to the longitudinal axis of needle 10 as in the first embodiment, but the axis of symmetry of slot 18 a is normal to the axis of symmetry of slot 18 .
  • the bottom of slot 18 a is proximal to the open upper end of slot 18 a .
  • a third sharp edge denoted 20 c .
  • Third sharp edge 20 c is auxiliary to first sharp edge 14 in that said third sharp edge scrapes cellular material from a lesion during proximal-to-distal travel of needle 10 .
  • FIGS. 8 and 9 depict fifth and sixth embodiments, respectively, where third sharp edges 20 d and 20 e are elevated and recessed, respectively, with respect to the exterior surface of needle 10 .
  • a seventh embodiment depicted in FIG. 10 , includes first slot 18 of the first embodiment and second slot 18 a of the fourth embodiment.
  • the respective axes of symmetry of said slots are normal to one another and said slots 18 and 18 a are longitudinally spaced apart from one another as depicted.
  • second sharp edge 20 is elevated or recessed relative to the exterior surface of needle 10 , as is third sharp edge 20 c.
  • FIG. 11 depicts an eighth embodiment.
  • This embodiment like the seventh, provides two auxiliary sharp edges to augment beveled edge 14 . However, it provides a single transversely disposed channel as distinguished from two transversely disposed slots. Thus, instead of slot 18 , transversely disposed channel 21 is formed in said needle 10 .
  • Channel 21 includes a pair of longitudinally spaced apart undercuts that respectively form second and third sharp edges 20 and 20 c .
  • Second sharp edge 20 performs in the same way as second sharp edge 20 of the first embodiment, i.e., it functions during distal-to-proximal travel of needle 10 .
  • Third sharp edge 20 c functions in the same way as third sharp edge 20 c of the fourth embodiment, i.e., during proximal-to-distal travel.
  • first sharp edge 14 and third sharp edge 20 c function during proximal-to-distal travel, but the amount of cellular material scraped from the lesion during such sharp action may not be the same.
  • This eighth embodiment is also similar to the seventh embodiment because second and third sharp edges 20 , 20 c are flush with the exterior surface of needle 10 .
  • FIGS. 12 and 13 depict ninth and tenth embodiments, respectively, where second sharp edge 20 f and third sharp edge 20 g are elevated, respectively, with respect to the exterior surface of needle 10 .
  • FIGS. 14 and 15 depict eleventh and twelfth embodiments, respectively, where second sharp edge 20 b and third sharp edge 20 e are recessed, respectively, with respect to the exterior surface of needle 10 .
  • FIG. 16 provides a longitudinal sectional view where second sharp edge 20 is pivotally mounted by transversely disposed hinge means 22 so that second sharp edge 20 may open as indicated by arcuate directional arrow 24 to the position indicated in dotted lines to scrape larger numbers of cells from the suspect lesion during distal-to-proximal travel of the biopsy needle.
  • Second sharp edge 20 is biased against outward rotation.
  • bias means such as different types of springs could be employed but the preferred bias means is a living hinge formed of nitenol or other suitable material. The hinge is held in its closed, FIG. 16 position when the needle is traveling in a proximal-to-distal direction, i.e., as the needle is inserted, but opens due to frictional forces created by the lesion as depicted in dotted lines in FIG. 16 when the needle is retracted, i.e., when the needle is displaced in a distal-to-proximal direction.
  • a control means not depicted, under the control of the physician, causes second sharp edge 20 to pivot about hinge means 22 in small incremental amounts so that the depth of the cellular aspirate taken from the lesion is controlled with precision.
  • sharp edges 20 a , 20 b , 20 c , 20 d , 20 e , 20 f , and 20 g could also be provided in pivotal form and placed under the control of the control means.
  • each sharp edge 20 , 20 a , 20 b , 20 c , 20 d , 20 e , 20 f , and 20 g may be enhanced by several differing means.
  • empirical studies may show that the cell-scraping ability of said sharp edges is enhanced by making said sharp edges abrasive.
  • the cut that forms sharp edges 20 , 20 a , 20 b , and 20 f is disposed substantially parallel to the bevel cut that forms first sharp edge 14 of needle 10 . Accordingly, said sharp edges scrape tissue with the same degree of efficiency as first sharp edge 14 .
  • the scraping action provided by these sharp edges is during the distal-to-proximal stroke of needle 10 whereas the scraping action provided by first sharp edge 14 is during the proximal-to-distal stroke.
  • the cut that forms third sharp edges 20 c , 20 d , 20 e , and 20 g is substantially normal to the cut that forms second sharp edges 20 , 20 a , 20 b , and 20 f .
  • the scraping action of said third sharp edges is during proximal-to-distal motion of the needle and as such said third sharp edges cut cellular material at the same time that first sharp edge 14 cuts cellular material.
  • a physician can reciprocate the needle along its longitudinal axis and obtain multiple cellular-sized samples of tissue for analysis.
  • Needle 10 is used by inserting it into a lesion in a well-known way and by reciprocating it multiple times along its longitudinal axis.
  • Each proximal-to-distal displacement causes first sharp edge 14 and third sharp edges 20 c , 20 d , 20 e , or 20 g , depending upon the embodiment used, to sever cells from the lesion and a vacuum pulls such cellular aspirate of the lesion into lumen 16 .
  • Each distal-to-proximal motion causes second sharp edges 20 , 20 a , 20 b , or 20 f , depending upon the embodiment used, to scrape off parts of the lesion.
  • novel aspiration biopsy needle 10 collects at least twice the amount of lesion material as would a conventional aspiration biopsy needle. The quantity of scraped-off lesion parts collected is increased with each subsequent reciprocation. In this way, a sufficient sample may be taken with a single needle insertion followed by multiple reciprocations.
  • Additional quantities of lesion material may also be collected by rotating needle 10 about its longitudinal axis of symmetry after a first set of reciprocations has been made. Additional rotations may follow additional reciprocations, it being understood that each rotational adjustment exposes an unscraped mass of lesion until the needle has been through three hundred sixty degrees of rotation.
  • FIG. 17 depicts how an endoscope or laparoscope 24 is used in connection with fine needle aspiration biopsy device 10 .
  • the well-known attachments to the endoscope such as a light source, camera unit, monitor, and the like are not depicted to avoid cluttering the drawing.
  • Syringe 26 is of conventional construction and is connected to an elongate, flexible polymer tube or a guide tube 28 of the hollow, coiled cable type. Tube wire 28 may be up to one hundred fifty centimeters (150 cm) in length and is inserted into the operating channel of the endoscope or laparoscope 24 as depicted.
  • Novel fine aspiration biopsy device 10 is secured to the distal end of the tube or guide wire 28 .

Abstract

A dual action biopsy needle scrapes tissue of cellular thickness from a lesion during proximal-to-distal travel of the needle along its longitudinal axis of symmetry. A first sharp edge, formed by a beveled distal end of the needle, scrapes tissue during proximal-to-distal travel of the needle. A transversely disposed slot formed in the needle near the first sharp edge provides a second sharp edge. A bottom of the slot is proximal to the opening of the slot. The second sharp edge also scrapes tissue during proximal-to-distal travel of the needle. The second sharp edge is coincident with an exterior surface of the needle. A vacuum pulls the scraped cellular material into the lumen of the needle.

Description

    CROSS-REFERENCE TO RELATED DISCLOSURES
  • This disclosure is a divisional application claiming the benefit of the filing date of pending U.S. patent application Ser. No. 10/708,710, filed Mar. 19, 2004 by the same inventor and having the same title, which is a pending divisional U.S. patent application claiming the benefit of the filing date of U.S. patent application Ser. No. 10/065,155, now U.S. Pat. No. 6,709,408, filed Sep. 23, 2002 by the same inventor and having the same title, which is a continuation-in-part of U.S. patent application Ser. No. 09/682,252, now abandoned, filed Aug. 9, 2001 by the same inventor and having the same title.
  • BACKGROUND OF THE INVENTION
  • 1. Field of the Invention
  • This invention relates, generally, to aspiration biopsy needles. More particularly, it relates to an aspiration biopsy needle having an enhanced cellular material collection capability.
  • 2. Description of the Prior Art
  • There are three main types of biopsy procedures. In a first type, a conventional surgical incision is made and the patient's body is opened so that a surgeon may retrieve one or more large pieces of the tumor or lesion to be tested for malignancy. This type of biopsy is very invasive, expensive to perform, and requires a considerable recovery time. Inventive endeavors in the field have resulted in two improved procedures that substantially reduce the invasiveness of the biopsy procedure, as well as the expense of the procedure and the length of the recovery time.
  • The first improved procedure involves the cutting or shearing of one or more visible pieces of the tumor or lesion by a relatively large bore needle. This type of biopsy is known as a core tissue biopsy and is performed with a core tissue biopsy needle. The pieces of tissue are usually about one to three millimeters in length and are thus visible to the unaided eye. They cannot be immediately examined under a microscope because they are too thick for light to pass therethrough. Accordingly, they must first be sliced into a plurality of very thin slices by a tissue-slicing machine. After slicing, they are then stained with a tissue fixative e.g., formalin, glutaraldehyde, etc., and placed upon a microscope slide for diagnostic purposes. For a period of time sufficient to cause crosslinking of connective tissue proteins present in the tissue, the fixed tissue is sliced into thin sections approximately eight (8) microns thick, the tissue sections are mounted on slides and cell-selective histological stains are applied to stain the tissue prior to microscopic examination. This non-frozen tissue preparation technique typically requires twenty four to forty eight (24-48) hours to complete so the pathologist's diagnosis of the breast lesion may not be available until twenty four to seventy two (24-72) hours after the biopsy specimen was removed from the breast. Accordingly, histopathological examination and diagnosis of breast lesions may be much more time-consuming than the histopathological examination and diagnosis of other types of lesions.
  • The use of a core tissue biopsy needle thus represents a significant improvement over the more invasive surgical removal of tumor or lesion specimens. However, the need to slice the specimens causes a delay in providing the diagnosis, due to processing. Additionally, the diameter of core biopsy needles are typically larger than the diameter of fine needle aspiration (FNA) needles, thereby increasing the risk of procedure-related complications including bleeding, pneumothorax, and bile leakage. Moreover, the use of core biopsy needles necessitates the purchase and maintenance of tissue slicing machines. The material must be removed from the needle, deposited onto the machine, machine-sliced, removed from the machine after slicing, stained, and deposited onto a microscope slide.
  • One example of a core tissue biopsy needle is disclosed in U.S. Pat. No. 5,320,110 to Wang. The Wang structure has utility in performing a pleural tissue biopsy by cutting tissue samples of the parietal pleura. Wang teaches a two needle (tube-in-tube) system having a sharp edge to fix tissue while a second needle is advanced to shear off a piece of the tissue. The device does not rely solely on a vacuum to draw in material as in an FNA biopsy needle and tissue is sheared off in sizeable, visible pieces, i.e., not at the cellular level.
  • More particularly, in the Wang device, a hook engages the pleural tissue and an outer cannula is advanced to cut off the hooked piece of pleural tissue. This two needle system is designed to reduce the chances of a pneumothorax and thus represents a significant improvement over earlier biopsy techniques. However, the diameter of the Wang needle as described is about 4.5 mm, which is considerably larger than an FNA biopsy needle of the novel type disclosed herein which is typically no larger than 20-22 gauge. The Wang needle is not designed as a fine needle aspiration device but is designed to cut off pieces of lung pleura. A large diameter needle like the Wang device measuring about 4.5 mm in diameter is inappropriate for fine needle biopsy procedures due to the high risk of complications from a large tissue puncture including bleeding, pneumothorax and bile leakage.
  • The Wang structure includes a notch formed in a first side of the large bore needle and a hole in an opposite side thereof. The tissue to be cut extends into the notch and is sliced off when the outer needle or cannula is advanced as aforesaid. No such opposing hole can be provided in an FNA biopsy needle because such hole would allow the escape of cellular material when it is deposited directly from the syringe barrel onto a microscope slide in which the distal tip bevel and side notch must point in the same direction.
  • The distal tip of the Wang outer needle is not hollow and therefore no tissue cutting occurs at said distal tip. All tissue cutting occurs at the side of the Wang needle where the notch is positioned. Thus, the Wang needle collects relatively large samples in a knifing action, and performs no scraping action capable of collecting samples at the cellular level.
  • Neither Wang nor any other known two needle systems include both an open distal end and a port for cutting tissue nor is any core biopsy system capable of collecting samples of cellular thickness. It should also be observed that the Wang needle is attached to a syringe barrel and includes a pressure flap.
  • Other biopsy tools that collect large specimens include spring-loaded core biopsy guns. An example of a vacuum-assisted biopsy device is the Mammotome Biopsys® breast biopsy device.
  • The third technique is called fine needle aspiration (FNA) biopsy and is performed with an FNA biopsy needle. An FNA biopsy needle scrapes cells from the tumor or lesion that are so small as to be invisible to the unaided eye. Advantageously, the cellular material is already very thin when it is collected so there is no need to slice it to a thinner size prior to viewing it on a microscope slide because light can already pass through the thin cell layer. The cellular material is deposited onto a microscope slide directly from the FNA biopsy needle, stained, and viewed so that there is less time to the final biopsy report because the slicing machine and all of the handling steps necessitated thereby are eliminated. Trauma to the patient is greatly reduced because of smaller needle diameter and because cells are scraped instead of tissue being cut in thick pieces. Complication risk is also minimized or eliminated due to smaller nozzle diameters.
  • FNA biopsy needles collect samples by aspiration; a vacuum applied to the proximal end of a hollow needle pulls severed cellular material from the lesion into the lumen of the needle. The needle is then retracted from the soft tissue so that the cellular material in the lumen can be removed for analysis. If more samples of the lesion are needed, the biopsy needle is reintroduced into the lesion.
  • The primary distinction between an FNA biopsy needle and a core tissue biopsy needle is that the latter cuts or slices relatively large pieces of tissue from a lesion or tumor whereas the former scrapes cellular material from a lesion or tumor. By way of analogy, a core needle aspiration biopsy needle is like a knife that cuts slices of cheese and an FNA biopsy needle is like a cheese grater that scrapes small flakes of cheese.
  • Sometimes, however, the FNA biopsy procedure fails to collect a sample of sufficient size to enable definitive pathological analysis. When that happens, the physician must repeat the procedure, causing additional trauma to the body part undergoing biopsy and creating an additional risk of an adverse event.
  • The primary reason that conventional FNA biopsy needles are sometimes unable to collect sufficient cellular material is that the only cutting action occurs at the hollow distal tip of the needle. Thus, no scraping occurs during the retraction stroke of the needle, i.e., scraping occur only in the forward thrust.
  • Although FNA biopsy needles represent a significant improvement over more invasive procedures for performing biopsies on suspect lesions or tumors, there remains a need for an improved FNA biopsy needle that increases the amount of sample that may be recovered per entrance into the lesion with one needle insertion so that multiple insertions need not be performed to complete a biopsy procedure.
  • However, in view of the prior art considered as a whole at the time the present invention was made, it was not obvious to those of ordinary skill in the pertinent art how the standard FNA biopsy needle could be improved.
  • SUMMARY OF THE INVENTION
  • The longstanding but heretofore unfulfilled need for a biopsy needle having enhanced cellular material collection capability is now met by a new, useful, and nonobvious invention. The novel aspiration biopsy needle includes a single needle of elongate, hollow construction having a proximal end and a beveled distal end. The beveled distal end of the needle is open and therefore forms a first sharp edge adapted to scrape cellular material when the needle is inserted into tissue. The needle is displaced from a proximal position to a distal position during insertion. The needle has a uniform diameter along a substantial part of its extent. A slot is formed in the needle near the beveled distal end; the slot is transversely disposed relative to a longitudinal axis of the needle. The slot is also angled relative to a transverse axis of the needle such that a bottom of the slot is positioned distal to an opening of the slot. The opening of the slot includes a second sharp edge adapted to scrape tissue of cellular size when the needle is displaced from a distal position to a proximal position. The novel structure further includes conventional means for applying a vacuum to a proximal end of the needle so that cellular material removed by the first sharp edge during proximal-to-distal travel of the needle is pulled into a lumen of the needle and so that cellular material removed by the second sharp edge during distal-to-proximal travel of the needle is also pulled into the lumen. However, the novel structure also has utility when no vacuum means is employed, i.e., even if it is not affixed to a syringe barrel.
  • Accordingly, the cellular material is deposited from the lumen of the single FNA needle onto a slide for microscopic inspection in the absence of any need to slice said cellular material and to place said cellular material, following staining, into a formative to preserve the tissue.
  • In all embodiments, the slot has a circumferential extent of about one half the circumference of the needle.
  • In a first embodiment, the second sharp edge is coincident with the exterior surface of the needle.
  • In a second embodiment, the second sharp edge is raised with respect to the exterior surface of said needle, and in a third embodiment, the sharp edge is recessed with respect to said exterior surface.
  • In a fourth embodiment, the slot is also angled relative to a transverse axis of the needle such that a bottom of the slot is positioned proximal to an opening of the slot and the second sharp edge thereby created is coincident with the exterior surface of the needle.
  • In fifth and sixth embodiments, the second sharp edge of the fourth embodiment is elevated and recessed, respectively, relative to the exterior surface of the needle.
  • In a seventh embodiment, a first slot is formed in the needle as in the first embodiment and a second slot is formed in the needle as in the fourth embodiment. The first and second slots are longitudinally spaced apart from one another.
  • In an eighth embodiment, a transversely disposed channel is formed in the needle and provides a second and a third sharp edge that are coincident with the exterior surface of the needle.
  • In ninth and tenth embodiments, the second and third sharp edges, respectively, are elevated with respect to the exterior surface of the needle and in eleventh and twelfth embodiments, the second and third sharp edges, respectively, are recessed with respect to said exterior surface.
  • In additional embodiments, the second sharp edge is mounted for pivotal movement about a transversely disposed hinge. The hinge enables the second sharp edge to open wider relative to its non-hinged position so that it may scrape off larger numbers of cellular material as the needle is displaced in a distal-to-proximal direction.
  • In still further embodiments, the third sharp edge is mounted for pivotal movement about a transversely disposed hinge and in additional embodiments, both the second and third sharp edges are so mounted.
  • A primary object of the invention is to provide a fine needle aspiration biopsy needle that collects a greater quantity of cellular material per needle insertion than conventional fine needle aspiration biopsy needles.
  • A closely related object is to accomplish the foregoing object by making a structural change to an existing FNA biopsy needle so that physicians will have a sense of familiarity when employing the improved needle.
  • A more specific object is to provide an FNA biopsy needle capable of collecting cellular material as the needle is reciprocated along its longitudinal axis at a tissue collection site.
  • These and other important objects, advantages, and features of the invention will become clear as this description proceeds.
  • The invention accordingly comprises the features of construction, combination of elements, and arrangement of parts that will be exemplified in the description set forth hereinafter and the scope of the invention will be indicated in the claims.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • For a fuller understanding of the nature and objects of the invention, reference should be made to the following detailed description, taken in connection with the accompanying drawings, in which:
  • FIG. 1 is a perspective view of a first embodiment of the novel aspiration biopsy needle;
  • FIG. 2 is an enlarged perspective view of the distal end of the needle of said first embodiment;
  • FIG. 3 is an enlarged longitudinal sectional view of the parts depicted in FIG. 2;
  • FIG. 4 is an enlarged perspective view of the distal end of a second embodiment;
  • FIG. 5 is an enlarged longitudinal sectional view of the parts depicted in FIG. 4;
  • FIG. 6 is an enlarged longitudinal sectional view of a third embodiment;
  • FIG. 7 is an enlarged longitudinal sectional view of a fourth embodiment;
  • FIG. 8 is an enlarged longitudinal sectional view of a fifth embodiment
  • FIG. 9 is an enlarged longitudinal sectional view of a sixth embodiment;
  • FIG. 10 is an enlarged longitudinal sectional view of a seventh embodiment;
  • FIG. 11 is an enlarged longitudinal sectional view of a eighth embodiment;
  • FIG. 12 is an enlarged sectional view of a ninth embodiment;
  • FIG. 13 is an enlarged sectional view of a tenth embodiment;
  • FIG. 14 is an enlarged sectional view of an eleventh embodiment;
  • FIG. 15 is an enlarged sectional view of a twelfth embodiment;
  • FIG. 16 is an enlarged sectional view of a thirteenth embodiment; and
  • FIG. 17 is a diagrammatic view of a fourteenth embodiment where the novel biopsy device is used with an endoscope.
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
  • Referring now to FIGS. 1-3, it will there be seen that the reference numeral 10 denotes a first illustrative embodiment of the present invention.
  • The proximal end 12 of aspiration biopsy needle 10 is mounted in a LUER LOK® adapter 13 or equivalent structure to which a vacuum is applied from a remote source of negative pressure, not shown, when the leading or distal end 14 of said needle is inserted into a suspect lesion in soft tissue. The sharp leading end 14 is beveled in a well-known way to form a first sharp edge that scrapes cellular material from the lesion as it travels therethrough in a proximal-to-distal direction.
  • A vacuum applied to adapter 13 pulls cellular material severed from the lesion into lumen 16 of the needle. The well-known prior art procedure ends at this point, i.e., the needle having a sample of the lesion in its lumen is retracted from the soft tissue and the sample is delivered to a lab for analysis. Additional sample-taking requires additional insertions of the needle into the lesion.
  • A first innovation of this invention includes slot 18 formed in needle 10, near first sharp edge 14 thereof. Slot 18 is transversely disposed relative to a longitudinal axis of the needle. A lower end or bottom of the slot is distal to the open upper end thereof. A second sharp edge 20 is formed at the distal edge of the upper end of the slot. Accordingly, second sharp edge 20 scrapes cellular material from a lesion when the needle is retracted, i.e., when the needle is displaced along its longitudinal axis in a distal-to-proximal direction.
  • It should therefore be understood that a physician may reciprocate needle 10 along its longitudinal axis, collecting cells of a suspect lesion that are scraped off by the first sharp edge 14 during the proximal-to-distal portion of each reciprocation, and collecting cellular aspirate of said lesion that are scraped by second sharp edge 20 during the distal-to-proximal portion of each reciprocation. Thus, the chances of collecting a quantity of lesion that is sufficient for analysis is greatly enhanced by the provision of second sharp edge 20.
  • The circumferential extent of slot 18 is approximately equal to half of the circumference of needle 10, but that structural feature of slot 18 is not critical to this invention; the circumferential extent of said slot could be more or less than that described and depicted.
  • As perhaps best depicted in FIG. 3, second sharp edge 20 is coincident or flush with the exterior surface of needle 10 in this first embodiment.
  • FIG. 4 provides a perspective view of a second embodiment of needle 10 where second sharp edge 20 a is elevated with respect to the exterior surface of needle 10 and FIG. 5 provides a longitudinal sectional view of said second embodiment. The protrusion of second sharp edge 20 a above the exterior surface of the needle ensures that the cellular material collected when using this second embodiment should be greater than the amount of cellular material collected when using the first embodiment.
  • FIG. 6 provides a longitudinal sectional view of a third embodiment where second sharp edge 20 b is recessed with respect to said exterior surface. The lesion, not shown, is under compression as needle 10 penetrates it. Accordingly, an amount of tissue will enter into slot 18 and be scraped off during distal-to-proximal travel of needle 10, even though sharp edge 20 b is recessed with respect to the exterior surface of the needle.
  • FIG. 7 depicts a fourth embodiment where a slot 18 a is formed transversely to the longitudinal axis of needle 10 as in the first embodiment, but the axis of symmetry of slot 18 a is normal to the axis of symmetry of slot 18. In other words, the bottom of slot 18 a is proximal to the open upper end of slot 18 a. Accordingly, a third sharp edge, denoted 20 c, is formed. Third sharp edge 20 c is auxiliary to first sharp edge 14 in that said third sharp edge scrapes cellular material from a lesion during proximal-to-distal travel of needle 10.
  • FIGS. 8 and 9 depict fifth and sixth embodiments, respectively, where third sharp edges 20 d and 20 e are elevated and recessed, respectively, with respect to the exterior surface of needle 10.
  • A seventh embodiment, depicted in FIG. 10, includes first slot 18 of the first embodiment and second slot 18 a of the fourth embodiment. The respective axes of symmetry of said slots are normal to one another and said slots 18 and 18 a are longitudinally spaced apart from one another as depicted. In undepicted variations or permutations of this embodiment, second sharp edge 20 is elevated or recessed relative to the exterior surface of needle 10, as is third sharp edge 20 c.
  • FIG. 11 depicts an eighth embodiment. This embodiment, like the seventh, provides two auxiliary sharp edges to augment beveled edge 14. However, it provides a single transversely disposed channel as distinguished from two transversely disposed slots. Thus, instead of slot 18, transversely disposed channel 21 is formed in said needle 10. Channel 21 includes a pair of longitudinally spaced apart undercuts that respectively form second and third sharp edges 20 and 20 c. Second sharp edge 20 performs in the same way as second sharp edge 20 of the first embodiment, i.e., it functions during distal-to-proximal travel of needle 10. Third sharp edge 20 c, however, functions in the same way as third sharp edge 20 c of the fourth embodiment, i.e., during proximal-to-distal travel. Thus, first sharp edge 14 and third sharp edge 20 c function during proximal-to-distal travel, but the amount of cellular material scraped from the lesion during such sharp action may not be the same. This eighth embodiment is also similar to the seventh embodiment because second and third sharp edges 20, 20 c are flush with the exterior surface of needle 10.
  • FIGS. 12 and 13 depict ninth and tenth embodiments, respectively, where second sharp edge 20 f and third sharp edge 20 g are elevated, respectively, with respect to the exterior surface of needle 10.
  • FIGS. 14 and 15 depict eleventh and twelfth embodiments, respectively, where second sharp edge 20 b and third sharp edge 20 e are recessed, respectively, with respect to the exterior surface of needle 10.
  • FIG. 16 provides a longitudinal sectional view where second sharp edge 20 is pivotally mounted by transversely disposed hinge means 22 so that second sharp edge 20 may open as indicated by arcuate directional arrow 24 to the position indicated in dotted lines to scrape larger numbers of cells from the suspect lesion during distal-to-proximal travel of the biopsy needle.
  • Second sharp edge 20 is biased against outward rotation. Various bias means such as different types of springs could be employed but the preferred bias means is a living hinge formed of nitenol or other suitable material. The hinge is held in its closed, FIG. 16 position when the needle is traveling in a proximal-to-distal direction, i.e., as the needle is inserted, but opens due to frictional forces created by the lesion as depicted in dotted lines in FIG. 16 when the needle is retracted, i.e., when the needle is displaced in a distal-to-proximal direction.
  • Alternatively, a control means, not depicted, under the control of the physician, causes second sharp edge 20 to pivot about hinge means 22 in small incremental amounts so that the depth of the cellular aspirate taken from the lesion is controlled with precision.
  • It should be understood that, in addition to first sharp edge 20 of the first embodiment, sharp edges 20 a, 20 b, 20 c, 20 d, 20 e, 20 f, and 20 g could also be provided in pivotal form and placed under the control of the control means.
  • Moreover, the cell-collection ability of each sharp edge 20, 20 a, 20 b, 20 c, 20 d, 20 e, 20 f, and 20 g may be enhanced by several differing means. For example, empirical studies may show that the cell-scraping ability of said sharp edges is enhanced by making said sharp edges abrasive. A polymer or polymers of the type that cellular material clings to could be added to the sharp edge or edges. Adhesive of the type that cellular material clings to could also be added to said sharp edge or edges.
  • As drawn, the cut that forms sharp edges 20, 20 a, 20 b, and 20 f is disposed substantially parallel to the bevel cut that forms first sharp edge 14 of needle 10. Accordingly, said sharp edges scrape tissue with the same degree of efficiency as first sharp edge 14. The scraping action provided by these sharp edges is during the distal-to-proximal stroke of needle 10 whereas the scraping action provided by first sharp edge 14 is during the proximal-to-distal stroke.
  • The cut that forms third sharp edges 20 c, 20 d, 20 e, and 20 g is substantially normal to the cut that forms second sharp edges 20, 20 a, 20 b, and 20 f. The scraping action of said third sharp edges is during proximal-to-distal motion of the needle and as such said third sharp edges cut cellular material at the same time that first sharp edge 14 cuts cellular material.
  • In this way, a physician can reciprocate the needle along its longitudinal axis and obtain multiple cellular-sized samples of tissue for analysis.
  • Needle 10 is used by inserting it into a lesion in a well-known way and by reciprocating it multiple times along its longitudinal axis. Each proximal-to-distal displacement causes first sharp edge 14 and third sharp edges 20 c, 20 d, 20 e, or 20 g, depending upon the embodiment used, to sever cells from the lesion and a vacuum pulls such cellular aspirate of the lesion into lumen 16. Each distal-to-proximal motion, however, causes second sharp edges 20, 20 a, 20 b, or 20 f, depending upon the embodiment used, to scrape off parts of the lesion. These scraped-off parts of the lesion enter into lumen 16 through slot 18, slot 18 a, or channel 21, depending upon the embodiment in use, under the influence of the vacuum. Thus, in a single reciprocation, novel aspiration biopsy needle 10 collects at least twice the amount of lesion material as would a conventional aspiration biopsy needle. The quantity of scraped-off lesion parts collected is increased with each subsequent reciprocation. In this way, a sufficient sample may be taken with a single needle insertion followed by multiple reciprocations.
  • Additional quantities of lesion material may also be collected by rotating needle 10 about its longitudinal axis of symmetry after a first set of reciprocations has been made. Additional rotations may follow additional reciprocations, it being understood that each rotational adjustment exposes an unscraped mass of lesion until the needle has been through three hundred sixty degrees of rotation.
  • FIG. 17 depicts how an endoscope or laparoscope 24 is used in connection with fine needle aspiration biopsy device 10. The well-known attachments to the endoscope such as a light source, camera unit, monitor, and the like are not depicted to avoid cluttering the drawing. Syringe 26 is of conventional construction and is connected to an elongate, flexible polymer tube or a guide tube 28 of the hollow, coiled cable type. Tube wire 28 may be up to one hundred fifty centimeters (150 cm) in length and is inserted into the operating channel of the endoscope or laparoscope 24 as depicted. Novel fine aspiration biopsy device 10 is secured to the distal end of the tube or guide wire 28. Although it is difficult to push device 10 to retrieve cellular material from lesion 30 as in the earlier embodiments, it can be pulled to collect such cellular material because it cuts at the cellular level in both forward and rearward motions. Pulling of guide tube 28 results in rearward motion of device 10.
  • These improvements represent revolutionary improvements in the art of aspiration biopsy needles and this invention is therefore entitled to the status of a pioneering invention. Accordingly, the claims that follow are entitled to broad interpretation, as a matter of law, to protect the heart or essence of the invention.
  • It will thus be seen that the objects set forth above, and those made apparent from the foregoing description, are efficiently attained. Since certain changes may be made in the above construction without departing from the scope of the invention, it is intended that all matters contained in the foregoing description or shown in the accompanying drawings shall be interpreted as illustrative and not in a limiting sense.
  • It is also to be understood that the following claims are intended to cover all of the generic and specific features of the invention herein described, and all statements of the scope of the invention which, as a matter of language, might be said to fall therebetween.
  • Now that the invention has been described,

Claims (9)

1. An aspiration biopsy needle, comprising: a needle of elongate, hollow construction having a proximal end and a beveled distal end; said needle having a uniform diameter along an extent of said needle; said beveled distal end being open and therefore forming a first sharp edge adapted to scrape cellular material when said needle is inserted into tissue, said needle being displaced from a proximal to a distal position during insertion; a slot formed in said needle near said beveled distal end; said slot being transversely disposed relative to a longitudinal axis of said needle; said slot also being angled relative to a transverse axis of said needle such that a bottom of said slot is positioned proximal to an opening of said slot; said opening of said slot being in open communication with an exterior surface of said needle; said slot including a second sharp edge adapted to scrape tissue of cellular size when said needle is displaced from a proximal position to a distal position; said second sharp edge being flush with said external surface of said needle; means for communicating a vacuum to said proximal end of said needle so that cellular material removed by said first sharp edge and said second sharp edge during proximal-to-distal travel of said needle is pulled into a lumen of said needle; and said needle being configured to deposit said cellular material from said lumen onto a slide to be stained and subjected to microscopic inspection in the absence of any need to mechanically slice said cellular material.
2. The needle of claim 1, wherein said slot has a circumferential extent of about one half the circumference of said needle.
3. The needle of claim 1, wherein a material to which cellular material clings is applied to said first and second sharp edges.
4. An aspiration biopsy needle, comprising: a needle of elongate, hollow construction having a proximal end and a beveled distal end; said needle having a uniform diameter along an extent of said needle; said beveled distal end being open and therefore forming a first sharp edge adapted to scrape cellular material when said needle is inserted into tissue, said needle being displaced from a proximal to a distal position during insertion; a slot formed in said needle near said beveled distal end; said slot being transversely disposed relative to a longitudinal axis of said needle; said slot also being angled relative to a transverse axis of said needle such that a bottom of said slot is positioned proximal to an opening of said slot; said opening of said slot being in open communication with an exterior surface of said needle; said slot including a second sharp edge adapted to scrape tissue of cellular size when said needle is displaced from a proximal position to a distal position; said second sharp edge being elevated relative to said external surface of said needle; means for communicating a vacuum to said proximal end of said needle so that cellular material removed by said first sharp edge and said elevated second sharp edge during proximal-to-distal travel of said needle is pulled into a lumen of said needle; and said needle being configured to deposit said cellular material from said lumen onto a slide to be stained and subjected to microscopic inspection in the absence of any need to mechanically slice said cellular material.
5. The needle of claim 4, wherein said slot has a circumferential extent of about one half the circumference of said needle.
6. The needle of claim 4, wherein a material to which cellular material clings is applied to said first and second sharp edges.
7. An aspiration biopsy needle, comprising: a needle of elongate, hollow construction having a proximal end and a beveled distal end; said needle having a uniform diameter along an extent of said needle; said beveled distal end being open and therefore forming a first sharp edge adapted to scrape cellular material when said needle is inserted into tissue, said needle being displaced from a proximal to a distal position during insertion; a slot formed in said needle near said beveled distal end; said slot being transversely disposed relative to a longitudinal axis of said needle; said slot also being angled relative to a transverse axis of said needle such that a bottom of said slot is positioned proximal to an opening of said slot; said opening of said slot being in open communication with an exterior surface of said needle; said slot including a second sharp edge adapted to scrape tissue of cellular size when said needle is displaced from a proximal position to a distal position; said second sharp edge being recessed relative to said external surface of said needle; means for communicating a vacuum to said proximal end of said needle so that cellular material removed by said first sharp edge and said recessed second sharp edge during proximal-to-distal travel of said needle is pulled into a lumen of said needle; and said needle being configured to deposit said cellular material from said lumen onto a slide to be stained and subjected to microscopic inspection in the absence of any need to mechanically slice said cellular material.
8. The needle of claim 7, wherein said slot has a circumferential extent of about one half the circumference of said needle.
9. The needle of claim 7, wherein a material to which cellular material clings is applied to said first and second sharp edges.
US10/905,599 2001-08-09 2005-01-12 Dual Action Aspiration Biopsy Needle Abandoned US20050090765A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/905,599 US20050090765A1 (en) 2001-08-09 2005-01-12 Dual Action Aspiration Biopsy Needle

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US09/682,252 US20030032895A1 (en) 2001-08-09 2001-08-09 Dual action aspiration biopsy needle
US10/065,155 US6709408B2 (en) 2001-08-09 2002-09-23 Dual action aspiration biopsy needle
US10/708,710 US6872185B2 (en) 2001-08-09 2004-03-19 Dual action aspiration biopsy needle
US10/905,599 US20050090765A1 (en) 2001-08-09 2005-01-12 Dual Action Aspiration Biopsy Needle

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/708,710 Division US6872185B2 (en) 2001-08-09 2004-03-19 Dual action aspiration biopsy needle

Publications (1)

Publication Number Publication Date
US20050090765A1 true US20050090765A1 (en) 2005-04-28

Family

ID=32028496

Family Applications (5)

Application Number Title Priority Date Filing Date
US10/065,155 Expired - Lifetime US6709408B2 (en) 2001-08-09 2002-09-23 Dual action aspiration biopsy needle
US10/708,712 Expired - Lifetime US6890309B2 (en) 2001-08-09 2004-03-19 Method for scraping cellular material from tissue
US10/708,711 Expired - Lifetime US6908440B2 (en) 2001-08-09 2004-03-19 Dual action aspiration biopsy needle
US10/708,710 Expired - Lifetime US6872185B2 (en) 2001-08-09 2004-03-19 Dual action aspiration biopsy needle
US10/905,599 Abandoned US20050090765A1 (en) 2001-08-09 2005-01-12 Dual Action Aspiration Biopsy Needle

Family Applications Before (4)

Application Number Title Priority Date Filing Date
US10/065,155 Expired - Lifetime US6709408B2 (en) 2001-08-09 2002-09-23 Dual action aspiration biopsy needle
US10/708,712 Expired - Lifetime US6890309B2 (en) 2001-08-09 2004-03-19 Method for scraping cellular material from tissue
US10/708,711 Expired - Lifetime US6908440B2 (en) 2001-08-09 2004-03-19 Dual action aspiration biopsy needle
US10/708,710 Expired - Lifetime US6872185B2 (en) 2001-08-09 2004-03-19 Dual action aspiration biopsy needle

Country Status (5)

Country Link
US (5) US6709408B2 (en)
EP (1) EP1542592A4 (en)
AU (1) AU2003267265A1 (en)
CA (1) CA2499993C (en)
WO (1) WO2004026142A1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070213634A1 (en) * 2006-02-24 2007-09-13 Boston Scientific Scimed, Inc. Obtaining a tissue sample
US20110137202A1 (en) * 2009-12-03 2011-06-09 M.I. Tech Co., Ltd. Biopsy needle device
WO2011073725A1 (en) * 2009-12-15 2011-06-23 Luc Malarme Handheld automated biopsy device
WO2011126963A3 (en) * 2010-04-06 2011-12-01 Cook Medical Technologies Llc Endoscopic ultrasound-guided biopsy needle
US20120078279A1 (en) * 2008-12-16 2012-03-29 Mark Joseph L Multi-functional surgical device for neurosurgical and spinal surgery applications
EP2455115A1 (en) * 2010-11-19 2012-05-23 Persat, Jean-Charles Sampling carrier for tissue, in particular adipose
US20130123623A1 (en) * 2011-07-06 2013-05-16 Olympus Medical Systems Corp. Specimen collection treatment instrument
US20140296741A1 (en) * 2011-07-21 2014-10-02 The General Hospital Corporation Method and apparatus for subsurface tissue sampling
CN104266860A (en) * 2014-10-16 2015-01-07 南通大学 Spring type brain slice sampler and sampling method thereof
US9149260B2 (en) 2014-02-28 2015-10-06 3DBiopsy LLC Biopsy needle assembly
WO2015066621A3 (en) * 2013-11-04 2015-11-05 The Board Of Regents Of The University Of Texas System Device and methods for precise control of medical procedures
US20160022489A1 (en) * 2013-03-13 2016-01-28 D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. Eye surgical cutting tool
US9615969B2 (en) 2012-12-18 2017-04-11 Novartis Ag Multi-port vitrectomy probe with dual cutting edges
US9693898B2 (en) 2014-11-19 2017-07-04 Novartis Ag Double-acting vitreous probe with contoured port
US9980707B2 (en) 2011-04-04 2018-05-29 Cook Medical Technologies Llc Endoscopic ultrasound-guided biopsy needle
US10251792B2 (en) 2013-02-20 2019-04-09 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
US10278677B2 (en) 2011-01-28 2019-05-07 The General Hospital Corporation Apparatus and method for tissue biopsy
US10327800B2 (en) 2011-01-28 2019-06-25 The General Hospital Corporation Method and apparatus for skin resurfacing
US10555754B2 (en) 2013-08-09 2020-02-11 Cytrellis Biosystems, Inc. Methods and apparatuses for skin treatment using non-thermal tissue ablation
US10639197B2 (en) 2017-06-19 2020-05-05 Alcon Inc. Vitrectomy probe
US10953143B2 (en) 2013-12-19 2021-03-23 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
US11166743B2 (en) 2016-03-29 2021-11-09 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
US11324534B2 (en) 2014-11-14 2022-05-10 Cytrellis Biosystems, Inc. Devices and methods for ablation of the skin
US11337720B2 (en) 2011-07-21 2022-05-24 The General Hospital Corporation Method and apparatus for damage and removal of fat
US11464954B2 (en) 2016-09-21 2022-10-11 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing

Families Citing this family (98)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8282573B2 (en) 2003-02-24 2012-10-09 Senorx, Inc. Biopsy device with selectable tissue receiving aperture orientation and site illumination
US7189206B2 (en) * 2003-02-24 2007-03-13 Senorx, Inc. Biopsy device with inner cutter
US7695492B1 (en) * 1999-09-23 2010-04-13 Boston Scientific Scimed, Inc. Enhanced bleed back system
US20060183973A1 (en) * 2001-01-12 2006-08-17 Kamrava Michael M Endoscopic devices and method of use
US6709408B2 (en) * 2001-08-09 2004-03-23 Biopsy Sciences, Llc Dual action aspiration biopsy needle
CA2479349C (en) 2002-03-19 2012-07-03 Bard Dublin Itc Limited Biopsy device and biopsy needle module that can be inserted into the biopsy device
EP1487346B1 (en) 2002-03-19 2005-08-31 Bard Dublin ITC Limited Vacuum biopsy device
DE10314240A1 (en) 2003-03-29 2004-10-07 Bard Dublin Itc Ltd., Crawley Pressure generating unit
US20050222683A1 (en) * 2004-03-31 2005-10-06 Sdgi Holdings Shape memory alloy disc replacement device
US7775968B2 (en) * 2004-06-14 2010-08-17 Pneumrx, Inc. Guided access to lung tissues
US20050288702A1 (en) * 2004-06-16 2005-12-29 Mcgurk Erin Intra-bronchial lung volume reduction system
WO2006014567A2 (en) * 2004-07-08 2006-02-09 Pneumrx, Inc. Pleural effusion treatment device, method and material
US7766891B2 (en) * 2004-07-08 2010-08-03 Pneumrx, Inc. Lung device with sealing features
ES2398914T3 (en) 2004-07-09 2013-03-22 Bard Peripheral Vascular, Inc. Transport system for biopsy device
US20060052722A1 (en) * 2004-09-09 2006-03-09 Brautigam Robert T Ultra-fine micropsy needle
US20060064031A1 (en) * 2004-09-17 2006-03-23 Miller Stuart H Biopsy needle
EP1816945B1 (en) 2004-11-23 2019-08-21 PneumRx, Inc. Steerable device for accessing a target site
CA2599455A1 (en) * 2005-01-28 2006-08-03 The General Hospital Corporation Biopsy needle
US7517321B2 (en) 2005-01-31 2009-04-14 C. R. Bard, Inc. Quick cycle biopsy system
US20060200041A1 (en) * 2005-03-04 2006-09-07 Ethicon Endo-Surgery, Inc. Biopsy device incorporating an adjustable probe sleeve
US7517322B2 (en) 2005-03-04 2009-04-14 Ethicon Endo-Surgery, Inc. Biopsy device with variable side aperture
WO2007021903A2 (en) 2005-08-10 2007-02-22 C.R. Bard Inc. Single-insertion, multiple sampling biopsy device with linear drive
ES2380208T3 (en) 2005-08-10 2012-05-09 C.R.Bard, Inc. Transport system for single insertion, biopsy devices for multiple samples
CA3060814C (en) 2005-08-10 2022-04-19 C.R. Bard, Inc. Single-insertion, multiple sample biopsy device with integrated markers
US8187203B2 (en) 2006-02-24 2012-05-29 Mcclellan W Thomas Biopsy needle system, biopsy needle and method for obtaining a tissue biopsy specimen
US7766843B2 (en) 2006-03-03 2010-08-03 Ethicon Endo-Surgery, Inc. Biopsy method
US20070208272A1 (en) * 2006-03-03 2007-09-06 Voegele James W Biopsy device
US7806834B2 (en) * 2006-03-07 2010-10-05 Devicor Medical Products, Inc. Device for minimally invasive internal tissue removal
US7670299B2 (en) * 2006-03-07 2010-03-02 Ethincon Endo-Surgery, Inc. Device for minimally invasive internal tissue removal
US9402633B2 (en) 2006-03-13 2016-08-02 Pneumrx, Inc. Torque alleviating intra-airway lung volume reduction compressive implant structures
US8721734B2 (en) * 2009-05-18 2014-05-13 Pneumrx, Inc. Cross-sectional modification during deployment of an elongate lung volume reduction device
US8888800B2 (en) 2006-03-13 2014-11-18 Pneumrx, Inc. Lung volume reduction devices, methods, and systems
US8157837B2 (en) * 2006-03-13 2012-04-17 Pneumrx, Inc. Minimally invasive lung volume reduction device and method
US7465278B2 (en) * 2006-03-29 2008-12-16 Ethicon Endo-Surgery, Inc. Device for minimally invasive internal tissue removal
JP4504941B2 (en) * 2006-04-25 2010-07-14 テルモ株式会社 Thrombus aspiration catheter
US8251917B2 (en) 2006-08-21 2012-08-28 C. R. Bard, Inc. Self-contained handheld biopsy needle
US20080058674A1 (en) * 2006-08-29 2008-03-06 Lex Jansen Tissue extraction device and method of using the same
US20080058673A1 (en) * 2006-08-29 2008-03-06 Lex Jansen Tissue extraction device and method of using the same
DK2086418T3 (en) 2006-10-06 2011-03-14 Bard Peripheral Vascular Inc Tissue management system with reduced operator exposure
US7914463B2 (en) * 2006-10-23 2011-03-29 Clipius Technologies, Inc. Double core biopsy instrumentation kit
EP2086417B1 (en) 2006-10-24 2015-07-01 C.R.Bard, Inc. Large sample low aspect ratio biopsy needle
US9345457B2 (en) * 2006-12-13 2016-05-24 Devicor Medical Products, Inc. Presentation of biopsy sample by biopsy device
WO2009058436A1 (en) * 2007-11-02 2009-05-07 Sharp Surgical Devices, Inc. Devices, methods, and kits for a biopsy device
US20090177114A1 (en) * 2007-12-13 2009-07-09 Yem Chin Echogenic needle aspiration device
US8241225B2 (en) 2007-12-20 2012-08-14 C. R. Bard, Inc. Biopsy device
US7854706B2 (en) 2007-12-27 2010-12-21 Devicor Medical Products, Inc. Clutch and valving system for tetherless biopsy device
US8632605B2 (en) 2008-09-12 2014-01-21 Pneumrx, Inc. Elongated lung volume reduction devices, methods, and systems
US8968210B2 (en) 2008-10-01 2015-03-03 Covidien LLP Device for needle biopsy with integrated needle protection
US9332973B2 (en) 2008-10-01 2016-05-10 Covidien Lp Needle biopsy device with exchangeable needle and integrated needle protection
US11298113B2 (en) 2008-10-01 2022-04-12 Covidien Lp Device for needle biopsy with integrated needle protection
US9782565B2 (en) 2008-10-01 2017-10-10 Covidien Lp Endoscopic ultrasound-guided biliary access system
US9186128B2 (en) 2008-10-01 2015-11-17 Covidien Lp Needle biopsy device
EP2389115B1 (en) * 2008-12-19 2018-02-28 Covidien LP Navigable tissue treatment tools
CA2751273A1 (en) 2009-03-16 2010-09-23 C.R. Bard, Inc. Biopsy device having rotational cutting
GB2469062B (en) * 2009-03-31 2011-06-15 Igal Gigi Tissue sampling device and method
EP3034008B1 (en) 2009-04-15 2018-09-12 C.R. Bard Inc. Fluid management
US20100280408A1 (en) * 2009-04-30 2010-11-04 Rusnak Joseph G Fine needle biopsy system and method of use
US9301736B2 (en) 2009-04-30 2016-04-05 Joseph G. Rusnak Fine needle biopsy with adaptor
US8206316B2 (en) 2009-06-12 2012-06-26 Devicor Medical Products, Inc. Tetherless biopsy device with reusable portion
EP2464294B1 (en) 2009-08-12 2019-10-02 C.R. Bard Inc. Biopsy appaparatus having integrated thumbwheel mechanism for manual rotation of biopsy cannula
US8430824B2 (en) 2009-10-29 2013-04-30 Bard Peripheral Vascular, Inc. Biopsy driver assembly having a control circuit for conserving battery power
US8485989B2 (en) 2009-09-01 2013-07-16 Bard Peripheral Vascular, Inc. Biopsy apparatus having a tissue sample retrieval mechanism
US9072506B1 (en) 2009-09-02 2015-07-07 C. R. Bard, Inc. Biopsy apparatus including a biopsy device having a sample receiving notch with a tissue anchor
US8597206B2 (en) 2009-10-12 2013-12-03 Bard Peripheral Vascular, Inc. Biopsy probe assembly having a mechanism to prevent misalignment of components prior to installation
US8529466B2 (en) 2010-03-30 2013-09-10 Siteselect Medical Technologies, Inc. Tissue excision device with rotating stylet blades
US9282948B2 (en) 2011-02-22 2016-03-15 Cook Medical Technologies Llc Total core biopsy device and method of use
JP5249472B2 (en) 2011-03-25 2013-07-31 オリンパスメディカルシステムズ株式会社 Biopsy treatment tool
US9060759B2 (en) 2011-03-31 2015-06-23 Cook Medical Technologies Llc Adjustable-throw biopsy needle
JP6180405B2 (en) 2011-05-03 2017-08-16 エンドーシー コーポレイションEndosee Corporation Methods and apparatus for hysteroscopy and endometrial biopsy
US10448930B2 (en) 2011-05-04 2019-10-22 Cook Medical Technologies Llc Methods and devices for maximizing tissue collection in partial-core biopsy needles
ES2601783T3 (en) * 2011-07-08 2017-02-16 Doheny Eye Institute Lens cutting device
US20130072912A1 (en) * 2011-09-19 2013-03-21 Daniel A. Del Vecchio Rasping cannula
US9445837B2 (en) 2012-03-16 2016-09-20 Nfinium Vascular Technologies Llc Surgical needle with enhanced ultrasound reflectivity
US9622646B2 (en) 2012-06-25 2017-04-18 Coopersurgical, Inc. Low-cost instrument for endoscopically guided operative procedures
US9192451B2 (en) * 2012-07-20 2015-11-24 Schubert L. Sapian Oscillating blade for cutting periodontal ligaments and luxating tooth roots
JP6263254B2 (en) 2013-03-14 2018-01-17 マフィン・インコーポレイテッドMuffin Incorporated Echogenic surface using Lulaw's triangle
US10092276B2 (en) 2013-03-15 2018-10-09 Cook Medical Technologies Llc Tissue acquisition device with indication system
CN105228532B (en) 2013-03-20 2018-04-27 巴德血管外围设备公司 Biopsy device
WO2014175698A1 (en) 2013-04-26 2014-10-30 서울대학교병원 Biopsy needle
US9795503B2 (en) 2013-10-18 2017-10-24 Rodolfo Alfredo PEREZ GROSSMANN Method and apparatus for trabeculectomy and suprachoroidal shunt surgery
WO2015069223A1 (en) 2013-11-05 2015-05-14 C.R. Bard, Inc. Biopsy device having integrated vacuum
US9993231B2 (en) 2013-11-20 2018-06-12 Covidien Lp Devices, systems, and methods for navigating a biopsy tool to a target location and obtaining a tissue sample using the same
US10278680B2 (en) 2014-03-19 2019-05-07 Covidien Lp Devices, systems, and methods for navigating a biopsy tool to a target location and obtaining a tissue sample using the same
KR20150116689A (en) * 2014-04-08 2015-10-16 주식회사 파인메딕스 Needle for EUS-FNA
US10390838B1 (en) 2014-08-20 2019-08-27 Pneumrx, Inc. Tuned strength chronic obstructive pulmonary disease treatment
US9980699B2 (en) 2014-09-12 2018-05-29 Cook Medical Technologies Llc Shaped echogenic needle groove
US9743915B2 (en) * 2014-10-30 2017-08-29 King Saud University Advanced biopsy needle
CN111281442B (en) 2015-05-01 2023-01-10 C·R·巴德公司 Biopsy device
US10702305B2 (en) 2016-03-23 2020-07-07 Coopersurgical, Inc. Operative cannulas and related methods
US10945713B2 (en) 2016-11-23 2021-03-16 C. R. Bard, Inc. Single insertion multiple sample biopsy apparatus
EP3338646A1 (en) 2016-12-21 2018-06-27 National University of Ireland Galway A biopsy device
WO2018213580A1 (en) 2017-05-19 2018-11-22 Merit Medical Systems, Inc. Rotating biopsy needle
EP3624698A4 (en) 2017-05-19 2021-06-09 Merit Medical Systems, Inc. Semi-automatic biopsy needle device and methods of use
WO2018213611A1 (en) 2017-05-19 2018-11-22 Merit Medical Systems, Inc. Biopsy needle devices and methods of use
WO2019038245A1 (en) * 2017-08-24 2019-02-28 Merck Patent Gmbh Method and device for providing a substance amount
KR102243139B1 (en) * 2018-08-08 2021-04-21 인제대학교 산학협력단 Needle for endoscopy ultrasonic fine needle aspiration biopsy
KR102475421B1 (en) 2020-07-06 2022-12-07 충남대학교병원 Production Metohd of Aspiration needle for preventing detachment of biopsy tissue
US11314427B2 (en) * 2020-08-21 2022-04-26 Micron Technology, Inc. Memory device with enhanced data reliability capabilities

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4702260A (en) * 1985-04-16 1987-10-27 Ko Pen Wang Flexible bronchoscopic needle assembly
US5320110A (en) * 1991-10-29 1994-06-14 Wang Ko P Pleural biopsy syringe-needles
US5560373A (en) * 1994-04-11 1996-10-01 De Santis; Stephen A. Needle core biopsy instrument with durable or disposable cannula assembly
US6872185B2 (en) * 2001-08-09 2005-03-29 Biopsy Sciences, Llc Dual action aspiration biopsy needle

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470867A (en) * 1964-11-23 1969-10-07 Sidney Goldsmith Biopsy needle
US3683892A (en) 1970-07-13 1972-08-15 Battelle Development Corp Device for the extraction of core samples
US4340066A (en) 1980-02-01 1982-07-20 Sherwood Medical Industries Inc. Medical device for collecting a body sample
DE3026657A1 (en) * 1980-07-14 1982-02-04 Battelle-Institut E.V., 6000 Frankfurt Puncturing needle for sample extraction - is hollow with recess with sharp edge below conventional opening
US4603694A (en) 1983-03-08 1986-08-05 Richards Medical Company Arthroscopic shaver
US4693257A (en) * 1986-05-12 1987-09-15 Markham Charles W Needle aspiration biopsy device with enclosed fluid supply
US4790329A (en) 1987-06-12 1988-12-13 Trustees Of Beth Israel Hospital Adjustable biopsy localization device
US4903709A (en) 1988-09-21 1990-02-27 Skinner Bruce A J Biopsy method
US5031634A (en) * 1990-01-19 1991-07-16 Beth Israel Hospital Assoc., Inc. Adjustable biopsy needle-guide device
GB2255282A (en) * 1991-04-30 1992-11-04 Al Sam Salam Zahroon Advanced fine needle for tissue aspiration.
US5425376A (en) 1993-09-08 1995-06-20 Sofamor Danek Properties, Inc. Method and apparatus for obtaining a biopsy sample
US5394887A (en) * 1994-01-14 1995-03-07 Haaga; John R. Biopsy needle
US5458112A (en) 1994-08-15 1995-10-17 Arrow Precision Products, Inc. Biliary biopsy device
US5615690A (en) * 1995-02-15 1997-04-01 Symbiosis Corporation Tissue core biopsy cannula
NL9500524A (en) * 1995-03-16 1996-11-01 Metracon C V Aspiration tool for cell biopsy purposes.
US5843111A (en) * 1995-06-19 1998-12-01 Ophthalmic Research Center International Bv Vitreous removing apparatus
US6024751A (en) * 1997-04-11 2000-02-15 Coherent Inc. Method and apparatus for transurethral resection of the prostate
US6022324A (en) 1998-01-02 2000-02-08 Skinner; Bruce A. J. Biopsy instrument
US6086543A (en) 1998-06-24 2000-07-11 Rubicor Medical, Inc. Fine needle and core biopsy devices and methods
JP2001149374A (en) * 1999-11-29 2001-06-05 Asahi Optical Co Ltd Tissue-collection instrument for endoscope
EP1132049B1 (en) * 2000-03-09 2004-09-08 Angiodynamics, Inc. Ultrasonic visible surgical needle
DE10032007A1 (en) * 2000-07-01 2002-01-10 Geuder Ag Ophthalmic surgical instrument with needle for taking biopsies has outer and inner housings sliding telescopically and holding cannula leading to collection vessel
US20050101879A1 (en) * 2003-11-06 2005-05-12 Shidham Vinod B. Needle aspiration biopsy device and method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4702260A (en) * 1985-04-16 1987-10-27 Ko Pen Wang Flexible bronchoscopic needle assembly
US5320110A (en) * 1991-10-29 1994-06-14 Wang Ko P Pleural biopsy syringe-needles
US5560373A (en) * 1994-04-11 1996-10-01 De Santis; Stephen A. Needle core biopsy instrument with durable or disposable cannula assembly
US6872185B2 (en) * 2001-08-09 2005-03-29 Biopsy Sciences, Llc Dual action aspiration biopsy needle
US6908440B2 (en) * 2001-08-09 2005-06-21 Biopsy Sciences, Llc Dual action aspiration biopsy needle

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007106170A2 (en) * 2006-02-24 2007-09-20 Boston Scientific Scimed, Inc. Obtaining a tissue sample
WO2007106170A3 (en) * 2006-02-24 2008-12-11 Boston Scient Scimed Inc Obtaining a tissue sample
US7473232B2 (en) * 2006-02-24 2009-01-06 Boston Scientific Scimed, Inc. Obtaining a tissue sample
US20090131826A1 (en) * 2006-02-24 2009-05-21 Boston Scientific Scimed, Inc. Obtaining a tissue sample
US7828746B2 (en) 2006-02-24 2010-11-09 Boston Scientific Scimed, Inc. Obtaining a tissue sample
US20070213634A1 (en) * 2006-02-24 2007-09-13 Boston Scientific Scimed, Inc. Obtaining a tissue sample
US10368890B2 (en) * 2008-12-16 2019-08-06 Nico Corporation Multi-functional surgical device for neurosurgical and spinal surgery applications
US20120078279A1 (en) * 2008-12-16 2012-03-29 Mark Joseph L Multi-functional surgical device for neurosurgical and spinal surgery applications
US20110137202A1 (en) * 2009-12-03 2011-06-09 M.I. Tech Co., Ltd. Biopsy needle device
WO2011073725A1 (en) * 2009-12-15 2011-06-23 Luc Malarme Handheld automated biopsy device
CN102843975A (en) * 2010-04-06 2012-12-26 库克医学技术有限责任公司 Endoscopic ultrasound-guided biopsy needle
US9986981B2 (en) 2010-04-06 2018-06-05 Cook Medical Technologies Llc Endoscopic ultrasound-guided notched biopsy needle
WO2011126963A3 (en) * 2010-04-06 2011-12-01 Cook Medical Technologies Llc Endoscopic ultrasound-guided biopsy needle
JP2013523333A (en) * 2010-04-06 2013-06-17 クック メディカル テクノロジーズ エルエルシー Endoscopic ultrasound guided biopsy needle
AU2011238490B2 (en) * 2010-04-06 2014-04-24 Cook Medical Technologies Llc Endoscopic ultrasound-guided biopsy needle
US8858461B2 (en) 2010-11-19 2014-10-14 Jean-Charles Persat Tissue sampling tool, in particular for adipose tissue
EP2455115A1 (en) * 2010-11-19 2012-05-23 Persat, Jean-Charles Sampling carrier for tissue, in particular adipose
FR2967567A1 (en) * 2010-11-19 2012-05-25 Jean-Charles Persat VECTOR FOR TISSUE PARTICULARLY ADIPOSE
US11419588B2 (en) 2011-01-28 2022-08-23 The General Hospital Corporation Apparatus and method for tissue biopsy
US11364049B2 (en) 2011-01-28 2022-06-21 The General Hospital Corporation Method and apparatus for skin resurfacing
US10327800B2 (en) 2011-01-28 2019-06-25 The General Hospital Corporation Method and apparatus for skin resurfacing
US10278677B2 (en) 2011-01-28 2019-05-07 The General Hospital Corporation Apparatus and method for tissue biopsy
US9980707B2 (en) 2011-04-04 2018-05-29 Cook Medical Technologies Llc Endoscopic ultrasound-guided biopsy needle
US8852113B2 (en) * 2011-07-06 2014-10-07 Olympus Medical Systems Corp. Specimen collection treatment instrument
US20130123623A1 (en) * 2011-07-06 2013-05-16 Olympus Medical Systems Corp. Specimen collection treatment instrument
US11337720B2 (en) 2011-07-21 2022-05-24 The General Hospital Corporation Method and apparatus for damage and removal of fat
US20140296741A1 (en) * 2011-07-21 2014-10-02 The General Hospital Corporation Method and apparatus for subsurface tissue sampling
US9615969B2 (en) 2012-12-18 2017-04-11 Novartis Ag Multi-port vitrectomy probe with dual cutting edges
US10251792B2 (en) 2013-02-20 2019-04-09 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
US11534344B2 (en) 2013-02-20 2022-12-27 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
US10543127B2 (en) 2013-02-20 2020-01-28 Cytrellis Biosystems, Inc. Methods and devices for skin tightening
US10231868B2 (en) * 2013-03-13 2019-03-19 D.O.R.C. Dutch Ophtalmic Research Center (International) B.V. Eye surgical cutting tool
US20160022489A1 (en) * 2013-03-13 2016-01-28 D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. Eye surgical cutting tool
US11083623B2 (en) 2013-03-13 2021-08-10 D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. Eye surgical cutting tool
US10555754B2 (en) 2013-08-09 2020-02-11 Cytrellis Biosystems, Inc. Methods and apparatuses for skin treatment using non-thermal tissue ablation
AU2014341912B2 (en) * 2013-11-04 2018-07-26 Fnapen Llc Device and methods for precise control of medical procedures
WO2015066621A3 (en) * 2013-11-04 2015-11-05 The Board Of Regents Of The University Of Texas System Device and methods for precise control of medical procedures
US10524833B2 (en) 2013-11-04 2020-01-07 Fnapen Llc Device and methods for precise control of medical procedures
US10953143B2 (en) 2013-12-19 2021-03-23 Cytrellis Biosystems, Inc. Methods and devices for manipulating subdermal fat
US9289192B2 (en) 2014-02-28 2016-03-22 3DBiopsy LLC Biopsy needle actuator assembly
US9149260B2 (en) 2014-02-28 2015-10-06 3DBiopsy LLC Biopsy needle assembly
CN104266860A (en) * 2014-10-16 2015-01-07 南通大学 Spring type brain slice sampler and sampling method thereof
US11324534B2 (en) 2014-11-14 2022-05-10 Cytrellis Biosystems, Inc. Devices and methods for ablation of the skin
US11896261B2 (en) 2014-11-14 2024-02-13 Cytrellis Biosystems, Inc. Devices and methods for ablation of the skin
US9693898B2 (en) 2014-11-19 2017-07-04 Novartis Ag Double-acting vitreous probe with contoured port
US11166743B2 (en) 2016-03-29 2021-11-09 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
US11464954B2 (en) 2016-09-21 2022-10-11 Cytrellis Biosystems, Inc. Devices and methods for cosmetic skin resurfacing
US10639197B2 (en) 2017-06-19 2020-05-05 Alcon Inc. Vitrectomy probe

Also Published As

Publication number Publication date
WO2004026142B1 (en) 2004-04-29
EP1542592A4 (en) 2009-06-03
AU2003267265A1 (en) 2004-04-08
US20040167435A1 (en) 2004-08-26
CA2499993A1 (en) 2004-04-01
US6890309B2 (en) 2005-05-10
US6872185B2 (en) 2005-03-29
US6709408B2 (en) 2004-03-23
US6908440B2 (en) 2005-06-21
US20030236471A1 (en) 2003-12-25
CA2499993C (en) 2013-08-06
WO2004026142A1 (en) 2004-04-01
EP1542592A1 (en) 2005-06-22
US20040167433A1 (en) 2004-08-26
US20040167434A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
US6709408B2 (en) Dual action aspiration biopsy needle
EP0808129B1 (en) Device for automated biopsy and collection of soft tissue
US6019733A (en) Biopsy apparatus and method
US20050113716A1 (en) Biopsy device having endoscope
US9381001B2 (en) Tissue splitting biopsy needle
US20160174950A1 (en) Fine needle biopsy with adaptor
US20150005662A1 (en) System and method for fine needle aspiration
US20140100448A1 (en) Rotary sample-collection needle
US20050070818A1 (en) Biopsy device with viewing assembly
US7722548B2 (en) Biopsy device
CN210903272U (en) Interventional puncture device
US20100280408A1 (en) Fine needle biopsy system and method of use
EP2595546B1 (en) Aspiration incision biopsy needle
US20030032895A1 (en) Dual action aspiration biopsy needle
GB2598433A (en) Rotatable tissue sampling device
Leitão et al. I. THE BASICS IN EUS-FNA
WO1993020753A1 (en) Biopsy needles

Legal Events

Date Code Title Description
AS Assignment

Owner name: BIOPSY SCIENCES, LLC, FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:FISHER, JOHN S;REEL/FRAME:015613/0234

Effective date: 20050123

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: MEDICAL DEVICE TECHNOLOGIES, INC., FLORIDA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BIOPSY SCIENCES, LLC;REEL/FRAME:019416/0571

Effective date: 20070122